Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Mesenchymal Stromal Cells Derived From Chronic Lymphocytic Leukemic Patients Express Different Genes and Produce Different Cytokines Compared to MSC Derived From Normal Subjects,

Wei Ding, MD, PhD, Traci Sassoon, Esteban Braggio, PhD, Charla Secreto, Neil Kay, MD

Blood (2011) 118 (21): 3872.

https://doi.org/10.1182/blood.V118.21.3872.3872

Published: 2011

Journal Articles

Prevalence of MBL Increases Over Time In Relatives of CLL Families,

Susan L Slager, PhD, Mark C Lanasa, MD, PhD, Sallie D. Allgood, MS, Sara J Achenbach, Aaron Norman, MS, Celine M Vachon, PhD, Lynn Goldin, PhD, Jose F. Leis, MD, PhD, Neil Kay, MD, J. Brice Weinberg, MD, Kari Rabe, MS, Timothy G. Call, MD, James R Cerhan, MD, PhD, Tait D. Shanafelt, MD, Neil E Caporaso, MD, Gerald E Marti, MD, PhD, Curtis A. Hanson, MD

Blood (2011) 118 (21): 3881.

https://doi.org/10.1182/blood.V118.21.3881.3881

Published: 2011

Journal Articles

Epigallocatechin-3-Gallate (EGCG) Modulates Cytokine Production When Leukemic CLL B-Cells and Marrow Stromal Cells Are Co-Cultured: Correlations with Clinical Activity in a Phase II Trial,

Connie Lesnick, Neil Kay, MD, Betsy R. LaPlant, Asish K Ghosh, PhD, Tait D. Shanafelt, MD

Blood (2011) 118 (21): 3882.

https://doi.org/10.1182/blood.V118.21.3882.3882

Published: 2011

Journal Articles

Variation in Health-Related Quality of Life by Age Among Patients with Chronic Lymphocytic Leukemia

Chris L. Pashos, PhD, Christopher R Flowers, MD, Mark Weiss, MD, Nicole Lamanna, MD, Charles M Farber, MD, PhD, Thomas J. Kipps, M.D., Ph.D, Susan Lerner, MS, BA, Neil Kay, MD, Jeff Porte Sharman, MD, David L. Grinblatt, MD, Ian W. Flinn, MD, PhD, Mark Kozloff, MD, Arlene S Swern, PhD, Zeba M. Kahn, Ph.D, Thomas K. Street, RPh, Kristen A Sullivan, MBA, Gale Harding, MA, Michael J Keating, MD

Blood (2011) 118 (21): 2085.

https://doi.org/10.1182/blood.V118.21.2085.2085

Published: 2011

Journal Articles

Ofatumumab Based Chemoimmunotherapy (CIT) for Patients with Previously Untreated CLL,

Tait D. Shanafelt, MD, Mark C Lanasa, MD, PhD, Clive S. Zent, MD, Jose F. Leis, MD, PhD, Timothy G Call, MD, Betsy R. LaPlant, Han Tun, MD, Deborah A. Bowen, Diane F. Jelinek, Ph.D., Curtis A. Hanson, MD, Neil Kay, MD

Blood (2011) 118 (21): 3898.

https://doi.org/10.1182/blood.V118.21.3898.3898

Published: 2011

Journal Articles

Lenalidomide Consolidation Appears to Prolong Time to Retreatment After First-Line Chemoimmunotherapy for Patients with Previously Untreated CLL,

Tait D. Shanafelt, MD, Han Tun, MD, Curtis A. Hanson, MD, Clive S. Zent, MD, Jose F. Leis, MD, PhD, Timothy G Call, MD, Betsy R. LaPlant, Deborah Bowen, EmilyS S Pavey, Diane F. Jelinek, Ph.D., Neil Kay, MD

Blood (2011) 118 (21): 3899.

https://doi.org/10.1182/blood.V118.21.3899.3899

Published: 2011

Journal Articles

Infectious Complications Among Individuals with Monoclonal B-Cell Lymphocytosis (MBL): A Prospective Case-Control Study of Newly Diagnosed Patients,

Jonathan Moreira, MD, Kari Rabe, MS, James R Cerhan, MD, PhD, Curtis A. Hanson, MD, Timothy G Call, MD, Clive S. Zent, MD, Jose F. Leis, MD, PhD, Deborah A. Bowen, John Wilson, MD, Neil Kay, MD, Susan Schwager, Randy F Wendt, Susan L Slager, PhD, Tait D. Shanafelt, MD

Blood (2011) 118 (21): 3903.

https://doi.org/10.1182/blood.V118.21.3903.3903

Published: 2011

Journal Articles

FISH Scoring for CLL: Comparison of Methods That Assess Round Versus Non-Round Nuclei,

Patricia T. Greipp, D.O., Stephanie A. Smoley, Neil Kay, MD, Clive S. Zent, MD, Jeannette E. Eckel-Passow, Ph.D., Ruchi G. Sharma, Daniel L. Van Dyke, Ph.D.

Blood (2011) 118 (21): 3538.

https://doi.org/10.1182/blood.V118.21.3538.3538

Published: 2011

Journal Articles

Axl Receptor Tyrosine Kinase Signaling Pathway and the p53 Tumor Suppressor Protein Exist In A Novel Regulatory Loop In B-Cell Chronic Lymphocytic Leukemia Cells

Asish K Ghosh, PhD, Justin Boysen, Tammy Price-troska, Charla Secreto, Clive S. Zent, MD, Neil Kay, MD

Blood (2011) 118 (21): 799.

https://doi.org/10.1182/blood.V118.21.799.799

Published: 2011

Journal Articles

Alemtuzumab Use and Survival After Reduced Intensity Allogeneic Stem Cell Transplantation in High-Risk Chronic Lymphocytic Leukemia (CLL),

Wei Ding, MD, PhD, Tait D. Shanafelt, MD, Kari Rabe, MS, Timothy G. Call, MD, Clive S. Zent, MD, Neil Kay, MD, David James Inwards, MD, Deborah Bowen, Mark R. Litzow, MD, Susan L Slager, PhD, Susan Schwager, William J Hogan, MBBCh

Blood (2011) 118 (21): 4152.

https://doi.org/10.1182/blood.V118.21.4152.4152

Published: 2011

Journal Articles

Patterns of Care for Patients with Chronic Lymphocytic Leukemia (CLL): The Connect ® CLL Disease Registry

Jeff Sharman, MD, Christopher R Flowers, MD, Mark Weiss, MD, David Grinblatt, MD, Charles Farber, MD, PhD, Neil Kay, MD, Thomas Kipps, MD, Nicole Lamanna, MD, Chris Pashos, PhD, Ian W Flinn, MD, Mark Kozloff, MD, Susan Lerner, MS, Arlene S Swern, PhD, Kristen A Sullivan, MBA, Thomas K. Street, RPh, Michael Keating, MBBS

Blood (2011) 118 (21): 2864.

https://doi.org/10.1182/blood.V118.21.2864.2864

Published: 2011

Journal Articles

Chronic Lymphocytic Leukemia Patients with IGHV Genes Carrying Only Silent Mutations Have A Longer Time From Diagnosis to Initial Therapy Than Patients Expressing B-Cell Receptors with No Somatic Mutations

Matthew Kaufman, MD, Xiao J. Yan, MD, PhD, Emanuela M. Ghia, PhD, Donna Neuberg, ScD, Laura Z. Rassenti, Ph.D., Kostas Stamatopoulos, MD, Paolo Ghia, MD, PhD, David G Oscier, MD, Frederic Davi, MD, PhD, Richard Rosenquist, MD, PhD, Chrysoula Belessi, MD, Zadie Davis, PhD, Andreas Agathangelidis, Neil Kay, MD, John C. Byrd, MD, Jennifer R Brown, MD, PhD, Kanti R. Rai, M.D., Thomas J. Kipps, M.D., Ph.D, Nicholas Chiorazzi, M.D.

Blood (2011) 118 (21): 288.

https://doi.org/10.1182/blood.V118.21.288.288

Published: 2011

Journal Articles

In Patients Newly Diagnosed with Chronic Lymphocytic Leukemia the Absolute Monocyte Count At Presentation Is Directly Associated with Disease Progression Independently From Rai Staging or Cytogenetics

Ryan A. Wilcox, MD, PhD, Kari Rabe, MS, Neil Kay, MD, Timothy G. Call, MD, Svetomir N. Markovic, MD, PhD, Luis F. Porrata, MD, Susan Schwager, Clive S. Zent, MD, Curtis A. Hanson, MD, Tait D. Shanafelt, MD

Blood (2011) 118 (21): 2835.

https://doi.org/10.1182/blood.V118.21.2835.2835

Published: 2011

Journal Articles

Resistance to Complement Dependent Cytotoxicity in CLL Cells From Patients Treated with Ofatumumab

Nisar A. Baig, Ronald P. Taylor, PhD, Margaret A. Lindorfer, PhD, Amy K Church, Betsy R. LaPlant, Emily S. Pavey, Tait D. Shanafelt, MD, Timothy G. Call, MD, Neil Kay, MD, Grzegorz S. Nowakowski, MD, Clive S. Zent, MD

Blood (2011) 118 (21): 2836.

https://doi.org/10.1182/blood.V118.21.2836.2836

Published: 2011

Journal Articles

Longitudinal Genome Wide Analysis of Patients with Chronic Lymphocytic Leukemia Reveals Complex Evolution of Clonal Architecture At Disease Progression and At the Time of Relapse

Esteban Braggio, PhD, Neil Kay, MD, Scott Van Wier, Renee C. Tschumper, Stephanie A. Smoley, Jeanette E. Eckel-Passow, Ph.D., Traci Sassoon, Daniel L. Van Dyke, Ph.D., John C. Byrd, MD, Diane F. Jelinek, Ph.D., Tait D. Shanafelt, MD, Rafael Fonseca, MD

Blood (2011) 118 (21): 2838.

https://doi.org/10.1182/blood.V118.21.2838.2838

Published: 2011

Journal Articles

Global Genomic Status At Diagnosis Informs Clinical Outcome in B-Chronic Lymphocytic Leukemia: Stable Versus Progressive Disease

Daniel L. Van Dyke, Ph.D., Jeannette G Rustin, Stephanie A. Smoley, Jeanette Eckel Passow, Ph.D., Ruchi G. Sharma, Esteban Braggio, PhD, Tait D. Shanafelt, MD, Neil Kay, MD

Blood (2011) 118 (21): 1772.

https://doi.org/10.1182/blood.V118.21.1772.1772

Published: 2011

Journal Articles

The Prevalence of Serious Infectious Complications in a Cohort of Non-Referred Patients with Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) Compared to Controls: Results of a Cohort Study

Jonathan Moreira, MD, Kari Rabe, MS, James R Cerhan, MD, PhD, John Wilson, MD, Neil Kay, MD, Clive S. Zent, MD, Deborah Bowen, Jose F. Leis, MD, PhD, Susan L Slager, PhD, Susan Schwager, Randy F Wendt, Timothy G Call, MD, Curtis A. Hanson, MD, Tait D. Shanafelt, MD

Blood (2011) 118 (21): 4610.

https://doi.org/10.1182/blood.V118.21.4610.4610

Published: 2011

Journal Articles

Variation in Health-Related Quality of Life by ECOG Performance Status and Fatigue Among Patients with Chronic Lymphocytic Leukemia

Chris L. Pashos, PhD, Christopher R Flowers, MD, Mark Weiss, MD, Nicole Lamanna, MD, Charles M Farber, MD, PhD, Thomas J. Kipps, M.D., Ph.D, Susan Lerner, MS, BA, Neil Kay, MD, Jeff Porte Sharman, MD, David L. Grinblatt, MD, Ian W. Flinn, MD, PhD, Mark Kozloff, MD, Arlene S Swern, PhD, Zeba M. Kahn, Ph.D, Thomas K. Street, RPh, Gale Harding, MA, Kristen A Sullivan, MBA, Michael J Keating, MD

Blood (2011) 118 (21): 4591.

https://doi.org/10.1182/blood.V118.21.4591.4591

Published: 2011

Journal Articles

TRIS (DIBENZYLIDENEACETONE) Dipalladium a Small-Molecule Palladium Complex Is Effective in the Induction of Apoptosis for B-Chronic Lymphocytic Leukemia B-Cells

Neil Kay, MD, Traci Sassoon, Charla Secreto, Asish K Ghosh, PhD, Jack L Arbiser

Blood (2011) 118 (21): 2851.

https://doi.org/10.1182/blood.V118.21.2851.2851

Published: 2011

Journal Articles

Pentostatin, Alemtuzumab, and Low Dose Rituximab Is Effective Therapy for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL)

Clive S. Zent, MD, Betsy R. LaPlant, Brian K Link, MD, Timothy G. Call, MD, Tait D. Shanafelt, MD, Deborah A. Bowen, Neil Kay, MD, George J. Weiner, MD, Thomas E. Witzig, MD

Blood (2011) 118 (21): 1790.

https://doi.org/10.1182/blood.V118.21.1790.1790

Published: 2011

NARROW

Mesenchymal Stromal Cells Derived From Chronic Lymphocytic Leukemic Patients Express Different Genes and Produce Different Cytokines Compared to MSC Derived From Normal Subjects,

Prevalence of MBL Increases Over Time In Relatives of CLL Families,

Epigallocatechin-3-Gallate (EGCG) Modulates Cytokine Production When Leukemic CLL B-Cells and Marrow Stromal Cells Are Co-Cultured: Correlations with Clinical Activity in a Phase II Trial,

Variation in Health-Related Quality of Life by Age Among Patients with Chronic Lymphocytic Leukemia

Ofatumumab Based Chemoimmunotherapy (CIT) for Patients with Previously Untreated CLL,

Lenalidomide Consolidation Appears to Prolong Time to Retreatment After First-Line Chemoimmunotherapy for Patients with Previously Untreated CLL,

Infectious Complications Among Individuals with Monoclonal B-Cell Lymphocytosis (MBL): A Prospective Case-Control Study of Newly Diagnosed Patients,

FISH Scoring for CLL: Comparison of Methods That Assess Round Versus Non-Round Nuclei,

Axl Receptor Tyrosine Kinase Signaling Pathway and the p53 Tumor Suppressor Protein Exist In A Novel Regulatory Loop In B-Cell Chronic Lymphocytic Leukemia Cells

Alemtuzumab Use and Survival After Reduced Intensity Allogeneic Stem Cell Transplantation in High-Risk Chronic Lymphocytic Leukemia (CLL),

Patterns of Care for Patients with Chronic Lymphocytic Leukemia (CLL): The Connect ® CLL Disease Registry

Chronic Lymphocytic Leukemia Patients with IGHV Genes Carrying Only Silent Mutations Have A Longer Time From Diagnosis to Initial Therapy Than Patients Expressing B-Cell Receptors with No Somatic Mutations

In Patients Newly Diagnosed with Chronic Lymphocytic Leukemia the Absolute Monocyte Count At Presentation Is Directly Associated with Disease Progression Independently From Rai Staging or Cytogenetics

Resistance to Complement Dependent Cytotoxicity in CLL Cells From Patients Treated with Ofatumumab

Longitudinal Genome Wide Analysis of Patients with Chronic Lymphocytic Leukemia Reveals Complex Evolution of Clonal Architecture At Disease Progression and At the Time of Relapse

Global Genomic Status At Diagnosis Informs Clinical Outcome in B-Chronic Lymphocytic Leukemia: Stable Versus Progressive Disease

The Prevalence of Serious Infectious Complications in a Cohort of Non-Referred Patients with Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) Compared to Controls: Results of a Cohort Study

Variation in Health-Related Quality of Life by ECOG Performance Status and Fatigue Among Patients with Chronic Lymphocytic Leukemia

TRIS (DIBENZYLIDENEACETONE) Dipalladium a Small-Molecule Palladium Complex Is Effective in the Induction of Apoptosis for B-Chronic Lymphocytic Leukemia B-Cells

Pentostatin, Alemtuzumab, and Low Dose Rituximab Is Effective Therapy for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only